James Terwilliger analyst

Currently out of the existing stock ratings of James Terwilliger, 17 are a BUY (77.27%), 5 are a HOLD (22.73%).

James Terwilliger

Work Performance Price Targets & Ratings Chart

Analyst James Terwilliger, carries an average stock price target met ratio of 41.98% that have a potential upside of 37.41% achieved within 354 days. Previously, James Terwilliger worked at NORTHLAND CAPITAL MARKETS, WUNDERLICH.

James Terwilliger’s has documented 43 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on INFU, InfuSystems Holdings at 29-Dec-2021.

Wall Street Analyst James Terwilliger

Analyst best performing recommendations are on ZYXI (ZYNEX).
The best stock recommendation documented was for ZYXI (ZYNEX) at 4/1/2020. The price target of $13.64 was fulfilled within 29 days with a profit of $4.72 (52.91%) receiving and performance score of 18.25.

Average potential price target upside

CSII Cardiovascular Systems HCSG Healthcare Services Group SRTS Sensus Healthcare ZYXI Zynex INFU InfuSystems Holdings ELMD Electromed

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Jan-2017

$25

$5 (25.00%)

$48

3 years 8 months 28 days ago
(14-Dec-2022)

4/8 (50%)

$10.95 (77.94%)

512

Hold Since 17-Jul-2019

$18

$-2 (-10.00%)

$18

4 years 3 months 3 days ago
(08-Jun-2022)

4/4 (100%)

$2.82 (18.58%)

146

Buy Since 22-Aug-2016

$20

$20

4 years 4 months 6 days ago
(05-May-2022)

13/16 (81.25%)

$4.32 (27.55%)

512

Buy Since 07-Apr-2020

$30

$10 (50.00%)

$34

4 years 4 months 7 days ago
(04-May-2022)

1/6 (16.67%)

$12.74 (73.81%)

295

Sell Since 02-Mar-2022

$22

$2 (10.00%)

4 years 6 months 9 days ago
(02-Mar-2022)

1/1 (100%)

$0.4 (1.85%)

27

Show more analysts

Please expand the browser size to see the chart

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?